Skip to main content

My new AFO dream: Cane or no Cane?

MS and would think after over thirty-three years as a public educator that I would tire of all the "alphabet" indicators, but it is just a way of life. 

At my new medical adviser's advice I began physical therapy two weeks ago and, if nothing else, am happy with the structured time dedicated to necessary stretching and strength building exercises. I am a bit more motivated to fight back against the MonSter.

Rebecca, my therapist, is extremely helpful, encouraging, and, and uplifting. She not only takes an interest in our time together, but is brutally honest in her assessment of my physical health. She goes out of her way to assist me in ways no other medical professional has...and she gets excited about doing so.

In fact, during tomorrow's appointment, I am to meet with a specialist to discuss the possibility of getting an affordable AFO (ankle foot orthosis) to light the offensive two on my right foot that interfere with walking. When Rebecca asked during my last appointment if I was excited bout this, I nearly cried (and probably will if/when I get the device). To walk again, unattended by my trusty albeit annoying cane! That is my dream. That is my goal. Yes, I will cry. 

My one and only experience with any type of AFO was a real slap in the face. You probably see the ads in MS magazines and neurology offices for L300 Go System electrical-stimulation rehabilitation device by Bioness. Several years ago during a extreme pro-active moment, I inquired about this device to the point that I actually visited an office in a neighboring town. They preformed an analysis of my situation, offered detailed informational literature and arranged for an agent to meet with me in order to "test drive" their wares.

The agent actually came to my work place after hours where I was fitted for the device and had an opportunity to walk around my empty classroom wearing the L300. 
                                                                                              L300 Plus System Benefits
                                                                                                   No, that's not me.
It was interesting and I kinda, sorta like it. 

But, then, we got the $ of the matter. Although this product has been approved by the FDA and is highly recommended to folks with foot drop due to stroke or other neurological situations, insurance does not cover any portion of the cost. 

The cost NOT in a school teacher's budget.

That shiny, new L300 was NOT and remains NOT in this Warrior's future. Probably because MS remains nonexistent in the minds of some insurance CEOs? (Facetious much, Lisa?)

Upon discussing this with Rebecca, she immediately became my personal champion by scheduling some time with an orthosis agent during a future PT session. Well, Rebecca delivered! Within  days I received a surprise phone call from said new hero telling me that this would happen this week! As in Friday! As in TOMORROW!

She asked me again on Tuesday if I was excited. What? Really?

Yes, Rebecca, I am over the moon excited.

Upon our first meeting, Rebecca inquired about my goal as a result of PT. I told her I wanted to take a walk without fear of falling. I wanted to walk down my street to my mother's house. I wanted to walk in the shopping mall. I wanted to walk to church two blocks away from my house. 

I didn't over-wish for the opportunity to accompany my husband to a WVU football game (haven't been to one in three years) where the trip from the parking lot to our seats is no longer an option for me. I didn't imagine walking from our camping trailer to the water's edge to throw in my fishing line during one of our long weekend off the grid. I'm not fantasizing about a hike in the woods.

But, I am hopeful.

And, hell-yeah, I'm excited. 

See ya tomorrow, Rebecca! I'll be the client who floats into the office. Oh, with my cane by my side.



Popular posts from this blog

Alien feet?

Okay, so after my initial reunion with social media, I naively imagined today to be more productive. But, no...

For someone who doesn't spend much time perusing sites like Pinterest, my interest has suddenly piqued to the point that addiction be a possibility.

Hoping to find someone of like mind, I instead downloaded a slipper pattern I might knit for Christmas presents (oops, there goes the surprise). It looks fairly simple. Let me know if you give it a try.

And, then, I found this really neat yoga flow outlined for me.
Since yoga seems to be the go-to exercise for us Warriors, I decided to share. That way we do not have to invent our own personalized routine. You're welcome.

Then, I discovered an entire page of memes that put MS in perspective to the causal reader-reluctant  on-looker. And because  this figure is essentially in the child pose... well, you get the picture.

Of course, any information on foot drop always attracts my at…

You are invited to Letters to the MonSter

Well, the sun is shining at last and it appears that spring is sincerely here and hinting at summer weather.    That means I need a summer project; hopefully one that I can complete. With two young adult books   in various levels of completion, you will surely tells me how ridiculous I am to start yet another writing project. but, inspiration has no rules, right?
           The entire month of March MS Awareness Month led to so many
awesomeavenues of expressions, fueling my need to share and learn with 
fellow MS Warriors. So, let's hare. Let's learn. In Letters to the MonSter, 
my goal is to allow fellow Warriors to vent, scream, rant, and exorcise the  MonSter out of our lives. Let's unite in this project to erase multiple sclerosis from our lives. As Leslie Hillburn stated in the preface to my last tome to this disease, "...the ONLY place you will get any support and understanding in dealing with me (MS) is with Other People wi…

MS and children

FDA Approves First Treatment for Pediatric MS On May 11, 2018, Novartis announced that Gilenya® (fingolimod) was approved by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents, ages 10 through 17, with relapsing multiple sclerosis (MS). This is the first disease-modifying therapy (DMT) to be approved for this form of the disease in this age group. Known as “pediatric MS,” nearly all of those diagnosed have the relapsing form of the disease. Children also experience approximately two-to-three times as many relapses as an individual with adult-onset MS. A clinical trial comparing Gilenya to Avonex® (interferon beta-1a) in children and adolescents found that those treated with Gilenya saw an 82-percent reduction in their annualized relapse rate over a period of up to two years. Please see MSAA's online news article, "FDA Approves Gilenya® for Pediatric MS,"for more information. If links are disabled in this email, please copy a…